We are live on
!
Find out more
Acadia Pharmaceuticals
ACAD
ACAD
267 hedge funds and large institutions have $2.99B invested in Acadia Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 51 funds opening new positions, 103 increasing their positions, 75 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
37% more repeat investments, than reductions
Existing positions increased: 103 | Existing positions reduced: 75
10% more call options, than puts
Call options by funds: $39.4M | Put options by funds: $35.9M
0.11% more ownership
Funds ownership: 97.99% → 98.1% (+0.11%)
7% less first-time investments, than exits
New positions opened: 51 | Existing positions closed: 55
3% less funds holding
Funds holding: 275 → 267 (-8)
41% less capital invested
Capital invested by funds: $5.04B → $2.99B (-$2.05B)
44% less funds holding in top 10
Funds holding in top 10: 9 → 5 (-4)
Holders
267
Holders Change
-8
Holders Change %
-2.91%
% of All Funds
3.85%
Holding in Top 10
5
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-44.44%
% of All Funds
0.07%
New
51
Increased
103
Reduced
75
Closed
55
Calls
$39.4M
Puts
$35.9M
Net Calls
+$3.47M
Net Calls Change
+$6.81M
Top Buyers
| 1 |
RI
RTW Investments
New York
|
+$63.8M |
| 2 |
Squarepoint
New York
|
+$18.1M |
| 3 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
+$16.4M |
| 4 |
Prudential Financial
Newark,
New Jersey
|
+$15.6M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$14.6M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$31.5M |
| 2 |
Morgan Stanley
New York
|
-$31.2M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$29.2M |
| 4 |
D.E. Shaw & Co
New York
|
-$27.6M |
| 5 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$25.8M |
